1yr
1yr
Safety and Efficacy of Canakinumab for the Prevention and Control of Type 2 Diabetes Mellitus and Its Complications: A Systematic Review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39286685/
Today, diabetes mellitus (DM) is one of the leading causes of morbidity and mortality globally.In this grim context, while our current armamentarium of anti-diabetic agents is vast and increasingly available,...
Canakinumab, an anti-IL-1β antibody, modestly affects glycemic control in T2DM while significantly reducing inflammation and cardiovascular events, demonstrating safety and tolerability in patients.
1yr
The effectiveness of telemedicine in the management of type 2 diabetes: A systematic review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39263639/
Telemedicine may be a valuable solution for blood sugar management in patients with type 2 diabetes. However, the effectiveness of telemedicine in improving BMI and quality of life is unclear.
Telemedicine shows promise in managing blood sugar levels in type 2 diabetes, though its impact on BMI and quality of life remains uncertain.
1yr
Improving outcomes of type 2 diabetes mellitus patients in primary care with Chronic Care Model: A narrative review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38966652/
Designed and implemented over two decades ago, the Chronic Care Model is a well-established chronic disease management framework that has steered several healthcare systems in successfully improving the clinical outcomes...
The Chronic Care Model, with its six key elements, significantly enhances primary care for type 2 diabetes, improving patient outcomes and clinical practices over the past two decades.
1yr
True or false? Alzheimer's disease is type 3 diabetes: Evidences from bench to bedside - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38955264/
Globally, Alzheimer's disease (AD) is the most widespread chronic neurodegenerative disorder, leading to cognitive impairment, such as aphasia and agnosia, as well as mental symptoms, like behavioral abnormalities, that place...
This review explores the connection between Alzheimer's disease and type 2 diabetes, focusing on insulin resistance, Aβ, oxidative stress, and other mechanisms, aiming to uncover potential therapeutic strategies.